NASDAQ : LGND
Ligand Pharmaceuticals Incorporated — Financial statements
Healthcare · Biotechnology · United States
Last price 317.33 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.33B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Ligand Pharmaceuticals Incorporated (LGND) reported revenue of 253.83M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 253.83M | 268.09M | 167.13M | 131.31M | 196.25M | 241.54M |
| Cost of Revenue | 35.22M | 95.73M | 32.50M | 35.05M | 88.91M | 94.28M |
| Gross Profit | 218.60M | 172.36M | 134.63M | 96.27M | 107.34M | 147.26M |
| Selling, General & Admin | 147.60M | 92.45M | 78.65M | 52.79M | 70.06M | 46.79M |
| Amortization of Goodwill & Intangibles | 34.49M | 32.71M | 32.96M | 33.65M | 34.24M | 34.22M |
| Operating Expenses | 182.10M | 125.16M | 111.61M | 86.44M | 104.30M | 81.01M |
| Operating Income | 36.51M | 47.20M | 23.02M | 9.82M | 3.04M | 66.25M |
| Interest Expense | -8.18M | -4.71M | -3.04M | -656.00K | -1.80M | -19.62M |
| Interest & Investment Income | 25.84M | 13.66M | 8.05M | 7.71M | 2.05M | 886.00K |
| Earnings From Equity Investments | 90.67M | 90.67M | -48.60M | -1.80M | ||
| Other Non Operating Income (Expenses) | 5.34M | -89.00K | -21.37M | 98.00K | -5.00K | -347.00K |
| EBT Excluding Unusual Items | 150.18M | 146.72M | -41.93M | 15.17M | 3.28M | 47.17M |
| Gain (Loss) on Sale of Investments | -91.25M | 18.43M | 75.02M | 46.37M | 28.54M | -5.26M |
| Gain (Loss) on Sale of Assets | 2.12M | |||||
| Asset Writedown | -6.20M | -6.20M | -30.57M | |||
| Other Unusual Items | 4.19M | 30.30M | ||||
| Pretax Income | 52.73M | 158.96M | 2.52M | 63.66M | 36.01M | 72.20M |
| Income Tax Expense | 1.27M | 34.51M | 6.55M | 9.84M | 41.23M | -4.15M |
| Earnings From Continuing Operations | 51.46M | 124.45M | -4.03M | 53.82M | -5.22M | 76.35M |
| Earnings From Discontinued Operations | -1.67M | -28.14M | -19.21M | |||
| Net Income to Company | 51.46M | 124.45M | -4.03M | 52.15M | -33.36M | 57.14M |
| Net Income | 51.46M | 124.45M | -4.03M | 52.15M | -33.36M | 57.14M |
| Net Income to Common | 51.46M | 124.45M | -4.03M | 52.15M | -33.36M | 57.14M |
| Shares Outstanding (Basic) | 19.79M | 19.34M | 18.29M | 17.30M | 16.87M | 16.63M |
| Shares Outstanding (Diluted) | 21.53M | 20.29M | 18.29M | 17.76M | 16.87M | 17.25M |
| EPS (Basic) | 2.60 | 6.44 | -0.22 | 3.02 | -1.98 | 3.44 |
| EPS (Diluted) | 2.39 | 6.13 | -0.22 | 2.94 | -1.98 | 3.32 |
| Free Cash Flow | 90.63M | 48.91M | 95.23M | 46.06M | 125.50M | 70.04M |
| Free Cash Flow Per Share | 4.21 | 2.41 | 5.21 | 2.59 | 7.44 | 4.06 |
| Gross Margin | 86.12% | 64.29% | 80.55% | 73.31% | 54.70% | 60.97% |
| Operating Margin | 14.38% | 17.61% | 13.77% | 7.48% | 1.55% | 27.43% |
| Profit Margin | 20.27% | 46.42% | -2.41% | 39.72% | -17.00% | 23.66% |
| Free Cash Flow Margin | 35.70% | 18.24% | 56.98% | 35.07% | 63.95% | 29.00% |
| EBITDA | 71.48M | 80.97M | 58.26M | 46.34M | 41.35M | 117.20M |
| EBITDA Margin | 28.16% | 30.20% | 34.86% | 35.29% | 21.07% | 48.52% |
| D&A For EBITDA | 34.97M | 33.77M | 35.24M | 36.52M | 38.32M | 50.95M |
| EBIT | 36.51M | 47.20M | 23.02M | 9.82M | 3.04M | 66.25M |
| EBIT Margin | 14.38% | 17.61% | 13.77% | 7.48% | 1.55% | 27.43% |
| Effective Tax Rate | 2.41% | 21.71% | 260.13% | 15.46% | 114.49% | |
| Revenue as Reported | 253.83M | 268.09M | 167.13M | 131.31M | 196.25M | 241.54M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 55.96M | 174.93M | 72.31M | 22.95M | 45.01M | 19.52M |
| Short-Term Investments | 391.44M | 558.59M | 183.86M | 147.35M | 166.86M | 321.59M |
| Cash & Short-Term Investments | 447.39M | 733.52M | 256.17M | 170.31M | 211.87M | 341.11M |
| Accounts Receivable | 110.72M | 82.39M | 48.40M | 32.92M | 30.42M | 85.45M |
| Other Receivables | 24.30M | 1.45M | 4.07M | 6.39M | 4.61M | 6.19M |
| Receivables | 135.01M | 83.84M | 52.47M | 39.31M | 35.04M | 91.65M |
| Inventory | 14.51M | 9.13M | 14.11M | 23.97M | 13.29M | 27.33M |
| Prepaid Expenses | 1.18M | 1.13M | ||||
| Restricted Cash | 4.11M | |||||
| Other Current Assets | 7.21M | 5.79M | 8.81M | 2.66M | 2.27M | 4.67M |
| Total Current Assets | 608.23M | 832.27M | 331.56M | 237.43M | 263.60M | 464.75M |
| Property, Plant & Equipment | 20.51M | 7.22M | 9.67M | 25.06M | 27.49M | 32.60M |
| Long-Term Investments | 142.92M | 167.95M | 10.91M | 49.32M | 3.00M | |
| Goodwill | 207.86M | 101.54M | 105.25M | 103.37M | 105.67M | 105.67M |
| Other Intangible Assets | 302.04M | 225.44M | 266.65M | 299.61M | 352.64M | 386.80M |
| Long-Term Accounts Receivable | 772.62M | 196.88M | 185.02M | 62.29M | ||
| Long-Term Deferred Tax Assets | 104.12M | 8.35M | 72.00K | 214.00K | 8.53M | 35.73M |
| Other Long-Term Assets | 79.16M | 20.99M | 32.64M | 9.92M | 1.74M | 272.03M |
| Total Assets | 2.24B | 1.56B | 941.77M | 787.22M | 762.67M | 1.30B |
| Accounts Payable | 4.09M | 3.24M | 5.23M | 2.43M | 5.31M | 8.40M |
| Accrued Expenses | 33.29M | 29.08M | 25.53M | 10.09M | 13.30M | 12.40M |
| Current Portion of Long-Term Debt | 448.31M | 76.69M | ||||
| Current Portion of Leases | 4.56M | 1.12M | 1.29M | 410.00K | 715.00K | 1.41M |
| Current Income Taxes Payable | 2.75M | 1.24M | 1.20M | |||
| Current Unearned Revenue | 1.22M | 355.00K | 654.00K | |||
| Other Current Liabilities | 7.58M | 2.77M | 3.86M | 2.63M | 2.43M | 18.80M |
| Total Current Liabilities | 500.57M | 37.45M | 37.11M | 16.78M | 98.81M | 41.66M |
| Long-Term Debt | 679.91M | 446.19M | 320.72M | |||
| Long-Term Leases | 21.43M | 4.23M | 5.86M | 5.77M | 10.34M | 2.31M |
| Long-Term Unearned Revenue | 18.18M | 15.14M | 44.00K | |||
| Long-Term Deferred Tax Liabilities | 22.40M | 36.02M | 32.52M | 31.62M | 30.61M | 30.86M |
| Other Long-Term Liabilities | 51.39M | 19.54M | 17.65M | 16.98M | 25.37M | 80.88M |
| Total Liabilities | 1.28B | 543.42M | 111.33M | 86.30M | 165.18M | 476.43M |
| Common Stock | 20.00K | 20.00K | 20.00K | 18.00K | 17.00K | 17.00K |
| Additional Paid-In Capital | 403.54M | 400.65M | 337.38M | 198.70M | 147.59M | 372.97M |
| Retained Earnings | 554.77M | 608.09M | 498.98M | 503.02M | 450.86M | 449.09M |
| Comprehensive Income & Other | 3.44M | 8.46M | -5.94M | -817.00K | -984.00K | -917.00K |
| Shareholders' Equity | 961.76M | 1.02B | 830.44M | 700.91M | 597.49M | 821.16M |
| Total Liabilities & Equity | 2.24B | 1.56B | 941.77M | 787.22M | 762.67M | 1.30B |
| Total Debt | 1.15B | 451.54M | 7.15M | 6.18M | 87.75M | 324.44M |
| Net Cash (Debt) | -706.81M | 281.98M | 249.01M | 164.12M | 124.12M | 16.66M |
| Net Cash Per Share | -32.82 | 13.89 | 13.61 | 9.24 | 7.36 | 0.97 |
| Filing Date Shares Outstanding | 20.00M | 19.94M | 19.26M | 17.71M | 17.08M | 16.85M |
| Total Common Shares Outstanding | 20.00M | 19.77M | 19.11M | 17.56M | 16.95M | 16.77M |
| Working Capital | 107.67M | 794.82M | 294.45M | 220.65M | 164.79M | 423.09M |
| Book Value Per Share | 48.09 | 51.44 | 43.46 | 39.92 | 35.25 | 48.97 |
| Tangible Book Value | 451.86M | 690.23M | 458.54M | 297.94M | 139.18M | 328.69M |
| Tangible Book Value Per Share | 22.59 | 34.91 | 24.00 | 16.97 | 8.21 | 19.60 |
| Machinery | 7.78M | 15.16M | 14.34M | |||
| Construction In Progress | 4.12M | |||||
| Leasehold Improvements | 10.36M | 7.45M | 5.26M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 51.46M | 124.45M | -4.03M | 52.15M | -33.36M | 57.14M |
| Depreciation & Amortization | 34.97M | 33.77M | 35.24M | 36.52M | 38.32M | 50.95M |
| Other Amortization | 6.67M | 3.21M | 2.61M | 1.98M | 6.25M | 21.53M |
| Loss (Gain) From Sale of Assets | -2.12M | |||||
| Asset Writedown & Restructuring Costs | 6.20M | 6.20M | 30.57M | 924.00K | ||
| Loss (Gain) From Sale of Investments | -4.75M | -167.13M | -34.63M | -47.68M | -28.52M | 4.11M |
| Loss (Gain) on Equity Investments | 7.01M | 1.83M | ||||
| Stock-Based Compensation | 56.70M | 46.85M | 41.09M | 25.74M | 50.88M | 38.78M |
| Other Operating Activities | -20.80M | 14.67M | -166.00K | 14.64M | 16.54M | -36.70M |
| Change in Accounts Receivable | -25.80M | -21.74M | -6.46M | -2.60M | 55.32M | -28.62M |
| Change in Inventory | -2.61M | 4.99M | 9.62M | -10.87M | 12.06M | -427.00K |
| Change in Accounts Payable | 8.91M | 5.88M | 13.90M | -4.70M | -3.34M | 2.81M |
| Change in Unearned Revenue | -4.00K | -578.00K | -1.31M | 419.00K | -6.28M | -17.87M |
| Change in Income Taxes | -22.25M | 2.67M | 2.31M | -1.78M | 1.58M | -3.98M |
| Change in Other Net Operating Assets | 2.34M | -3.89M | 1.29M | -14.87M | 6.34M | -8.93M |
| Operating Cash Flow | 91.03M | 49.36M | 97.05M | 49.58M | 137.85M | 78.80M |
| Capital Expenditures | -405.00K | -452.00K | -1.82M | -3.52M | -12.35M | -8.76M |
| Cash Acquisitions | -782.85M | -10.40M | ||||
| Divestitures | -8.09M | -8.09M | ||||
| Sale (Purchase) of Intangibles | 494.00K | |||||
| Investment in Securities | 159.87M | -349.73M | -136.08M | 52.15M | 182.41M | 40.01M |
| Other Investing Activities | -37.85M | -19.05M | -5.77M | -49.91M | -6.44M | -1.22M |
| Investing Cash Flow | -669.33M | -377.32M | -143.66M | -11.68M | 163.62M | 30.52M |
| Long-Term Debt Issued | 460.00M | |||||
| Long-Term Debt Repaid | -113.28M | -25.00K | -76.90M | -261.00M | -164.95M | |
| Net Debt Issued (Repaid) | 504.18M | 346.72M | -25.00K | -76.90M | -261.00M | -164.95M |
| Issuance of Common Stock | 31.18M | 47.50M | 102.73M | 22.45M | 3.23M | 33.76M |
| Repurchase of Common Stock | -82.45M | -24.60M | -5.14M | -4.55M | -8.24M | -6.02M |
| Other Financing Activities | 91.79M | 58.60M | -426.00K | -949.00K | -9.98M | -558.00K |
| Financing Cash Flow | 544.69M | 428.22M | 97.14M | -59.95M | -275.99M | -137.76M |
| Foreign Exchange Rate Adjustments | -2.38M | 2.36M | -1.17M | |||
| Net Cash Flow | -35.98M | 102.62M | 49.35M | -22.05M | 25.48M | -28.44M |
| Free Cash Flow | 90.63M | 48.91M | 95.23M | 46.06M | 125.50M | 70.04M |
| Free Cash Flow Margin | 35.70% | 18.24% | 56.98% | 35.07% | 63.95% | 29.00% |
| Free Cash Flow Per Share | 4.21 | 2.41 | 5.21 | 2.59 | 7.44 | 4.06 |
| Levered Free Cash Flow | 62.45M | 87.09M | 100.78M | 46.03M | 136.93M | 37.03M |
| Unlevered Free Cash Flow | 63.45M | 88.76M | 102.20M | 46.20M | 137.33M | 32.60M |
| Cash Interest Paid | 2.46M | 321.00K | 263.00K | 288.00K | 1.43M | 3.03M |
| Cash Income Tax Paid | 8.07M | 7.80M | 19.21M | 8.77M | 11.64M | 3.72M |
| Change in Working Capital | -39.41M | -12.66M | 19.36M | -34.40M | 65.68M | -57.00M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 6.46B | 3.72B | 2.02B | 1.25B | 1.13B | 2.58B |
| Enterprise Value | 7.16B | 3.51B | 1.81B | 1.06B | 1.12B | 2.59B |
| Last Close Price | 322.75 | 189.07 | 107.15 | 71.42 | 66.80 | 99.67 |
| PE Ratio | 134.96 | 29.90 | 23.88 | 45.18 | ||
| Forward PE | 44.68 | 35.20 | 53.58 | 35.07 | 298.37 | 298.37 |
| PS Ratio | 25.43 | 13.88 | 12.11 | 9.48 | 5.75 | 10.69 |
| PB Ratio | 6.71 | 3.66 | 2.44 | 1.78 | 1.89 | 3.14 |
| P/TBV Ratio | 14.29 | 5.39 | 4.42 | 4.18 | 8.11 | 7.85 |
| P/FCF Ratio | 71.24 | 76.09 | 21.26 | 27.04 | 8.99 | 36.86 |
| P/OCF Ratio | 70.92 | 75.39 | 20.86 | 25.12 | 8.19 | 32.76 |
| PEG Ratio | 1.83 | 2.42 | 3.57 | 2.34 | 23.42 | 18.19 |
| EV/Sales Ratio | 28.22 | 13.08 | 10.84 | 8.08 | 5.71 | 10.72 |
| EV/EBITDA Ratio | 100.21 | 43.32 | 31.11 | 22.90 | 27.11 | 22.09 |
| EV/EBIT Ratio | 196.20 | 74.32 | 78.73 | 108.04 | 369.11 | 39.07 |
| EV/FCF Ratio | 79.03 | 71.72 | 19.03 | 23.04 | 8.93 | 36.96 |
| Debt / Equity Ratio | 1.20 | 0.44 | 0.01 | 0.01 | 0.15 | 0.40 |
| Debt / EBITDA Ratio | 16.01 | 5.52 | 0.12 | 0.13 | 2.09 | 2.74 |
| Debt / FCF Ratio | 12.74 | 9.23 | 0.07 | 0.13 | 0.70 | 4.63 |
| Net Debt / Equity Ratio | 0.73 | -0.28 | -0.30 | -0.23 | -0.21 | -0.02 |
| Net Debt / EBITDA Ratio | 9.89 | -3.48 | -4.27 | -3.54 | -3.00 | -0.14 |
| Net Debt / FCF Ratio | 7.80 | -5.77 | -2.62 | -3.56 | -0.99 | -0.24 |
| Asset Turnover | 0.14 | 0.21 | 0.19 | 0.17 | 0.19 | 0.18 |
| Inventory Turnover | 2.67 | 8.24 | 1.71 | 1.88 | 4.38 | 3.50 |
| Quick Ratio | 1.16 | 21.83 | 8.32 | 12.49 | 2.50 | 10.39 |
| Current Ratio | 1.22 | 22.23 | 8.93 | 14.15 | 2.67 | 11.15 |
| Return on Equity (ROE) | 5.38% | 13.47% | -0.53% | 8.29% | -0.74% | 9.98% |
| Return on Assets (ROA) | 1.23% | 2.36% | 1.66% | 0.79% | 0.18% | 3.11% |
| Return on Invested Capital (ROIC) | 2.96% | 5.61% | -6.59% | 1.64% | -0.07% | 8.50% |
| Return on Capital Employed (ROCE) | 2.10% | 3.10% | 2.50% | 1.30% | 0.50% | 5.30% |
| Earnings Yield | 0.74% | 3.34% | -0.20% | 4.19% | -2.96% | 2.21% |
| FCF Yield | 1.40% | 1.31% | 4.70% | 3.70% | 11.12% | 2.71% |
| Buyback Yield / Dilution | -10.50% | -10.96% | -3.00% | -5.27% | 2.19% | -2.50% |